US20110023869A1 - Delivery devices - Google Patents
Delivery devices Download PDFInfo
- Publication number
- US20110023869A1 US20110023869A1 US12/516,401 US51640107A US2011023869A1 US 20110023869 A1 US20110023869 A1 US 20110023869A1 US 51640107 A US51640107 A US 51640107A US 2011023869 A1 US2011023869 A1 US 2011023869A1
- Authority
- US
- United States
- Prior art keywords
- delivery device
- outlet
- cavity
- substance
- mouthpiece
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000126 substance Substances 0.000 claims abstract description 28
- 239000007788 liquid Substances 0.000 claims description 32
- 239000012530 fluid Substances 0.000 claims description 8
- 239000000443 aerosol Substances 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 230000002093 peripheral effect Effects 0.000 claims description 3
- 238000011144 upstream manufacturing Methods 0.000 claims description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0091—Inhalators mechanically breath-triggered
- A61M15/0098—Activated by exhalation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/006—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/06—Sprayers or atomisers specially adapted for therapeutic purposes of the injector type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0005—Details of inhalators; Constructional features thereof with means for agitating the medicament
- A61M15/0006—Details of inhalators; Constructional features thereof with means for agitating the medicament using rotating means
- A61M15/0008—Details of inhalators; Constructional features thereof with means for agitating the medicament using rotating means rotating by airflow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/002—Details of inhalators; Constructional features thereof with air flow regulating means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0031—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up by bursting or breaking the package, i.e. without cutting or piercing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0086—Inhalation chambers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0091—Inhalators mechanically breath-triggered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/08—Inhaling devices inserted into the nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
Definitions
- the present invention relates to a delivery device for and method of delivering a metered volume of substance, in particular a delivery device for delivering a metered volume of a liquid substance to a nasal cavity of a subject.
- Very many delivery devices exist for the delivery of liquid substances, which typically comprise a manually-actuated pump for the delivery of a liquid substance as an aerosol spray.
- the present invention provides a delivery device for delivering a metered amount of substance in response to exhalation by a user, the delivery device comprising: a mouthpiece through which the user in use exhales; an outlet from which substance is delivered; and a dispensing unit which is operable to dispense a metered amount of substance through the outlet in response to exhalation by the user through the mouthpiece, wherein the dispensing unit comprises a body member which includes a cavity for containing a metered amount of substance, an outlet nozzle which is fluidly connected to the cavity from which substance is in use delivered, and a dispensing member which is movably disposed in the cavity and configured to be driven through the cavity by a driving pressure created by exhalation of the user, such as to cause substance to be delivered from the outlet nozzle.
- the cavity is an elongate cavity.
- the cavity has a cylindrical section and the dispensing member comprises a ball which is moved along the cavity by the driving pressure created by exhalation of the user.
- the ball sealingly engages with an inner peripheral wall of the cavity.
- the cavity and the dispensing member are configured to provide for movement of the dispensing member at a driving pressure of less than about 5 kPa, and preferably less than about 3 kPa.
- the outlet nozzle provides for an aerosol spray.
- the outlet nozzle provides for a substantially rectilinear flow for a distance of at least about 15 mm, preferably at least about 20 mm, more preferably at least about 25 mm and yet more preferably at least about 30 mm from exit of the outlet nozzle.
- outlet nozzle provides for a jet.
- the delivery device further comprises: a pressure regulator which is fluidly connected to the dispensing unit, such as to provide for application of a predeterminable driving pressure to the dispensing member.
- the mouthpiece and the outlet are fluidly connected, such as to provide for an air flow through the outlet on exhalation by the user through the mouthpiece.
- the delivery device further comprises: a housing in which the dispensing unit is disposed and to which the mouthpiece and the nosepiece are fluidly connected, such as to define a fluid communication path therebetween.
- the delivery device further comprises: a baffle member which is disposed in the fluid communication path.
- the baffle member includes a first, driving air pressure channel which is fluidly connected to the dispensing unit and at which the driving pressure is created on exhalation by the user to actuate the dispensing unit, and at least one second, entraining air flow channel through which an entraining air flow is delivered for entraining substance as delivered by the dispensing unit.
- the baffle member includes a plurality of entraining air flow channels.
- the housing includes an inlet chamber upstream of the baffle member which flares outwardly from the mouthpiece.
- the housing includes an outlet chamber downstream of the baffle member.
- the outlet chamber surrounds the dispensing unit.
- the outlet includes a flow restrictor for providing a flow restriction thereat.
- the flow restrictor tapers inwardly in a flow direction from the mouthpiece to the nosepiece.
- the flow restrictor has a frusto-conical section.
- the delivery device further comprises: a flow regulator which is disposed at the outlet nozzle of the dispensing unit.
- the flow regulator includes a plurality of flow apertures which are located on an annulus surrounding the outlet nozzle.
- the delivery device is configured to deliver a liquid.
- the outlet is a nosepiece and the delivery device is a nasal delivery device for delivering substance to a nasal airway of a subject.
- FIG. 1 illustrates a part-sectional perspective view of a delivery device in accordance with a preferred embodiment of the present invention
- FIG. 2 illustrates a longitudinal sectional view of the delivery device of FIG. 1 , where in the rest or non-actuated state;
- FIGS. 3( a ) to ( c ) illustrate three delivery profiles for the delivered substance obtainable by the delivery device of FIG. 1 ;
- FIG. 4 illustrates the delivery device of FIG. 1 , where in the actuated state
- FIG. 5 illustrates a part-sectional perspective view of a delivery device as a modification of the delivery device of FIG. 1 ;
- FIG. 6 illustrates a longitudinal sectional view of the delivery device of FIG. 5 .
- the delivery device comprises a first, inlet housing part 3 which defines a mouthpiece 5 at one, inlet end thereof and an inlet chamber 7 which is in fluid communication with the mouthpiece 5 and the other, outlet end of which is open, such that exhalation by a user into the mouthpiece 5 delivers an air flow into the inlet chamber 7 and to the open, outlet end thereof.
- the mouthpiece 5 comprises a tubular section which is gripped in the lips of the user.
- the inlet chamber 7 flares outwardly from the mouthpiece 5 , here having a frusto-conical section.
- the delivery device further comprises a baffle member 11 which sealingly engages the open, outlet end of the inlet chamber 7 , such as to direct the air flow as delivered through the inlet chamber 7 .
- the baffle member 11 includes a first, driving air pressure channel 21 at which a driving pressure is created, which acts to drive a liquid dispensing unit 35 , as will be described in more detail hereinbelow, and at least one, in this embodiment a plurality of second, entraining air flow channels 23 through which an entraining air flow F is delivered.
- the first, driving air pressure channel 21 is located on the longitudinal axis of the inlet chamber 7 .
- the driving air pressure channel 21 has a circular section, here having a diameter of at or less than about 6 mm.
- the entraining air flow channels 23 are located such as to be in fluid communication with the periphery of the open, outlet end of the inlet chamber 7 .
- the baffle member 11 includes four entraining air flow channels 23 which are disposed uniformly on an annulus about the longitudinal axis of the inlet housing part 3 , and each have a circular section, here having a diameter of at or less than about 4 mm.
- the baffle member 11 comprises first and second baffle elements 25 , 27 , here plates which are disposed in juxtaposed relation.
- the delivery device further comprises a pressure regulator 29 which includes an aperture 31 which is fluidly connected to the driving air pressure channel 21 in the baffle member 11 , in this embodiment at the downstream end thereof, such as to provide for the generation of a predetermined pressure thereat.
- the aperture 31 has a circular section, here having a diameter of at or less than about 4 mm.
- the delivery device further comprises a liquid dispensing unit 35 which is fluidly connected to the pressure regulator 29 such as to be actuated by the driving air pressure P as generated on exhalation by the user through the mouthpiece 5 .
- the liquid dispensing unit 35 comprises a body member 37 , in this embodiment a tubular member, here of cylindrical section, which defines an elongate cavity 39 which contains a metered dose of a liquid L, a dispensing member 41 which is movably disposed in the cavity 39 , such as to be moved along the cavity 39 under the action of the driving air pressure P and thereby dispense the liquid L from the cavity 39 , and an outlet nozzle 43 which is configured to provide for dispensing of the liquid L at a predetermined rate.
- a body member 37 in this embodiment a tubular member, here of cylindrical section, which defines an elongate cavity 39 which contains a metered dose of a liquid L
- a dispensing member 41 which is movably disposed in the cavity 39 , such as to be moved along the cavity 39 under the action of the driving air pressure P and thereby dispense the liquid L from the cavity 39
- an outlet nozzle 43 which is configured to provide for dispensing of the liquid L at a predetermined rate.
- the cavity 39 has a volume of about 1 ml. In another embodiment the cavity 39 could have a volume of or less than about 200 ⁇ l.
- the dispensing member 41 is initially disposed at one end of the cavity 39 adjacent the flow regulator 29 and is moved to the other end of the cavity 39 under the action of the driving air pressure, with the liquid L as contained in the cavity 39 being progressively dispensed as the dispensing member 41 is moved along the cavity 39 .
- the dispensing member 41 and the cavity 39 of the liquid dispensing unit 35 are configured to provide for movement with a driving air pressure P at or less than about 5 kPa and preferably at or less than about 3 kPa.
- the dispensing member 41 is a ball which sealingly engages the peripheral wall of the cavity 39 .
- the outlet nozzle 43 includes an outlet orifice 45 which is shaped and dimensioned, in this embodiment having a circular section, to provide the dispensed liquid with a predetermined profile.
- the outlet orifice 45 is configured to dispense the liquid L such that the flow of liquid L remains substantially rectilinear for a distance of at least about 15 mm, preferably at least about 20 mm, more preferably at least about 25 mm and yet more preferably at least about 30 mm from the exit of the outlet orifice 45 and thereafter provide a dispersed aerosol spray, as illustrated in FIG. 3( a ).
- outlet orifice 45 can be configured to provide a liquid jet, either with some dispersion in the form of a shower of droplets, as illustrated in FIG. 3( b ), or with no dispersion, as illustrated in FIG. 3( c ).
- the outlet orifice 45 has a diameter of at or less than about 3 mm, preferably at or less than about 2 mm, and more preferably at or less than about 1 mm.
- the outlet nozzle 43 includes a frangible membrane which normally encloses the outlet orifice 45 thereof such as to contain the liquid L and is ruptured on the application of the driving air pressure P to the liquid L.
- the delivery device further comprises a second, outlet housing part 51 which defines a nosepiece 53 at one, outlet end thereof and an outlet chamber 57 , in this embodiment an annular chamber surrounding the body member 37 of the liquid dispensing unit 35 , which is in fluid communication with the entraining air flow channels 23 in the baffle member 11 and opens to an outlet end thereof, such that exhalation by a user into the mouthpiece 5 delivers an entraining air flow F into the outlet chamber 57 and to the open, outlet end thereof.
- a second, outlet housing part 51 which defines a nosepiece 53 at one, outlet end thereof and an outlet chamber 57 , in this embodiment an annular chamber surrounding the body member 37 of the liquid dispensing unit 35 , which is in fluid communication with the entraining air flow channels 23 in the baffle member 11 and opens to an outlet end thereof, such that exhalation by a user into the mouthpiece 5 delivers an entraining air flow F into the outlet chamber 57 and to the open, outlet end thereof.
- the delivery device further comprises a flow regulator 61 which encloses the annular outlet chamber 57 at the outlet end of the body member 37 of the liquid dispensing unit 35 .
- the flow regulator 61 includes a plurality of flow apertures 63 , in this embodiment sixteen apertures, which are located on an annulus surrounding the body member 37 of the liquid dispensing unit 35 , such as to provide for the delivery of a substantially annular entraining air flow F which entrains the liquid L as dispensed from the liquid-containing cavity 39 of the liquid dispensing unit 35 .
- the flow regulator 61 is configured to provide for a flow rate of at least about 20 l/min, more preferably at least about 30 l/min, still more preferably at least about 40 l/min and yet more preferably at least about 50 l/min.
- the flow apertures 63 have a circular section, here of a diameter of at or less than about 1 mm.
- a user first inserts the nosepiece 53 into one of his/her nostrils and then grips the mouthpiece 5 in his/her lips.
- the delivery device has been illustrated in an elongate configuration where the nosepiece 53 and the mouthpiece 5 are located on a common axis.
- the nosepiece 53 and the mouthpiece 5 would be inclined relative to one another, such as to facilitate fitting of the nosepiece 53 and the mouthpiece 5 in respective ones of a nostril and the lips.
- This exhalation acts to generate a driving air pressure P at the driving air pressure channel 21 in the baffle member 11 and an entraining air flow F through the entraining air flow channels 23 in the baffle member 11 , which entraining air flow F continues through the outlet chamber 57 and the flow apertures 63 in the entraining air flow regulator 61 , which define a substantially annular entraining air flow F which surrounds the outlet end of the liquid dispensing unit 35 .
- the driving air pressure P as created at the driving air pressure channel 21 simultaneously acts on the dispensing member 41 , which is located in the cavity 39 of the liquid dispensing unit 35 , such as to move the same along the cavity 39 and dispense the liquid L as contained therein from the outlet end thereof into the entraining air flow F, which surrounds the same, thereby providing for delivery of the liquid L, in this embodiment into the nasal cavity of the user.
- the delivery device in providing for the delivery of the liquid L in an entraining air flow F, advantageously provides for delivery into and through the nasal airway in the manner as described in the applicant's earlier WO-A-2000/051672, the content of which is herein incorporated by reference.
- the delivery device can further comprise a flow restrictor 71 at the outlet end of the outlet housing part 51 which defines the nosepiece 53 .
- the flow restrictor 71 tapers inwardly, here with a frusto-conical section 73 , towards the outlet end of the outlet housing part 51 .
- the flow restrictor 71 defines an outlet which has a circular section.
- the outlet of the flow restrictor 71 has a diameter of at or less than about 8 mm, preferably at or less than about 6 mm and more preferably at or less than about 4 mm, and the angle of the tapering section 73 of the flow restrictor 71 has an angle of at or less than about 60 degrees, preferably at or less than about 55 degrees and more preferably at or less than about 52 degrees relative to a plane perpendicular to the longitudinal axis of the outlet housing part 51 .
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Anesthesiology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- Mechanical Engineering (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Biophysics (AREA)
- Reciprocating Pumps (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
Abstract
Description
- The present invention relates to a delivery device for and method of delivering a metered volume of substance, in particular a delivery device for delivering a metered volume of a liquid substance to a nasal cavity of a subject.
- Very many delivery devices exist for the delivery of liquid substances, which typically comprise a manually-actuated pump for the delivery of a liquid substance as an aerosol spray.
- Whilst these delivery devices have found extensive application, the present inventors have recognized the need for a delivery device which utilizes the exhalation breath of a user as the driving force to deliver a metered dose of a liquid substance.
- In one aspect the present invention provides a delivery device for delivering a metered amount of substance in response to exhalation by a user, the delivery device comprising: a mouthpiece through which the user in use exhales; an outlet from which substance is delivered; and a dispensing unit which is operable to dispense a metered amount of substance through the outlet in response to exhalation by the user through the mouthpiece, wherein the dispensing unit comprises a body member which includes a cavity for containing a metered amount of substance, an outlet nozzle which is fluidly connected to the cavity from which substance is in use delivered, and a dispensing member which is movably disposed in the cavity and configured to be driven through the cavity by a driving pressure created by exhalation of the user, such as to cause substance to be delivered from the outlet nozzle.
- In one embodiment the cavity is an elongate cavity.
- In one embodiment the cavity has a cylindrical section and the dispensing member comprises a ball which is moved along the cavity by the driving pressure created by exhalation of the user.
- In one embodiment the ball sealingly engages with an inner peripheral wall of the cavity.
- In one embodiment the cavity and the dispensing member are configured to provide for movement of the dispensing member at a driving pressure of less than about 5 kPa, and preferably less than about 3 kPa.
- In one embodiment the outlet nozzle provides for an aerosol spray.
- In one embodiment the outlet nozzle provides for a substantially rectilinear flow for a distance of at least about 15 mm, preferably at least about 20 mm, more preferably at least about 25 mm and yet more preferably at least about 30 mm from exit of the outlet nozzle.
- In another embodiment the outlet nozzle provides for a jet.
- In one embodiment the delivery device further comprises: a pressure regulator which is fluidly connected to the dispensing unit, such as to provide for application of a predeterminable driving pressure to the dispensing member.
- In one embodiment the mouthpiece and the outlet are fluidly connected, such as to provide for an air flow through the outlet on exhalation by the user through the mouthpiece.
- In one embodiment the delivery device further comprises: a housing in which the dispensing unit is disposed and to which the mouthpiece and the nosepiece are fluidly connected, such as to define a fluid communication path therebetween.
- In one embodiment the delivery device further comprises: a baffle member which is disposed in the fluid communication path.
- In one embodiment the baffle member includes a first, driving air pressure channel which is fluidly connected to the dispensing unit and at which the driving pressure is created on exhalation by the user to actuate the dispensing unit, and at least one second, entraining air flow channel through which an entraining air flow is delivered for entraining substance as delivered by the dispensing unit.
- In one embodiment the baffle member includes a plurality of entraining air flow channels.
- In one embodiment the housing includes an inlet chamber upstream of the baffle member which flares outwardly from the mouthpiece.
- In one embodiment the housing includes an outlet chamber downstream of the baffle member.
- In one embodiment the outlet chamber surrounds the dispensing unit.
- In one embodiment the outlet includes a flow restrictor for providing a flow restriction thereat.
- In one embodiment the flow restrictor tapers inwardly in a flow direction from the mouthpiece to the nosepiece.
- In one embodiment the flow restrictor has a frusto-conical section.
- In one embodiment the delivery device further comprises: a flow regulator which is disposed at the outlet nozzle of the dispensing unit.
- In one embodiment the flow regulator includes a plurality of flow apertures which are located on an annulus surrounding the outlet nozzle.
- In one embodiment the delivery device is configured to deliver a liquid.
- In one embodiment the outlet is a nosepiece and the delivery device is a nasal delivery device for delivering substance to a nasal airway of a subject.
- A preferred embodiment of the present invention will now be described hereinbelow by way of example only with reference to the accompanying drawings, in which:
-
FIG. 1 illustrates a part-sectional perspective view of a delivery device in accordance with a preferred embodiment of the present invention; -
FIG. 2 illustrates a longitudinal sectional view of the delivery device ofFIG. 1 , where in the rest or non-actuated state; -
FIGS. 3( a) to (c) illustrate three delivery profiles for the delivered substance obtainable by the delivery device ofFIG. 1 ; -
FIG. 4 illustrates the delivery device ofFIG. 1 , where in the actuated state; -
FIG. 5 illustrates a part-sectional perspective view of a delivery device as a modification of the delivery device ofFIG. 1 ; and -
FIG. 6 illustrates a longitudinal sectional view of the delivery device ofFIG. 5 . - The delivery device comprises a first,
inlet housing part 3 which defines amouthpiece 5 at one, inlet end thereof and aninlet chamber 7 which is in fluid communication with themouthpiece 5 and the other, outlet end of which is open, such that exhalation by a user into themouthpiece 5 delivers an air flow into theinlet chamber 7 and to the open, outlet end thereof. - In this embodiment the
mouthpiece 5 comprises a tubular section which is gripped in the lips of the user. - In this embodiment the
inlet chamber 7 flares outwardly from themouthpiece 5, here having a frusto-conical section. - The delivery device further comprises a
baffle member 11 which sealingly engages the open, outlet end of theinlet chamber 7, such as to direct the air flow as delivered through theinlet chamber 7. - The
baffle member 11 includes a first, drivingair pressure channel 21 at which a driving pressure is created, which acts to drive a liquid dispensingunit 35, as will be described in more detail hereinbelow, and at least one, in this embodiment a plurality of second, entrainingair flow channels 23 through which an entraining air flow F is delivered. - In this embodiment the first, driving
air pressure channel 21 is located on the longitudinal axis of theinlet chamber 7. In this embodiment the drivingair pressure channel 21 has a circular section, here having a diameter of at or less than about 6 mm. - In this embodiment the entraining
air flow channels 23 are located such as to be in fluid communication with the periphery of the open, outlet end of theinlet chamber 7. In this embodiment thebaffle member 11 includes four entrainingair flow channels 23 which are disposed uniformly on an annulus about the longitudinal axis of theinlet housing part 3, and each have a circular section, here having a diameter of at or less than about 4 mm. - In this embodiment the
baffle member 11 comprises first andsecond baffle elements - The delivery device further comprises a
pressure regulator 29 which includes anaperture 31 which is fluidly connected to the drivingair pressure channel 21 in thebaffle member 11, in this embodiment at the downstream end thereof, such as to provide for the generation of a predetermined pressure thereat. In this embodiment theaperture 31 has a circular section, here having a diameter of at or less than about 4 mm. - The delivery device further comprises a
liquid dispensing unit 35 which is fluidly connected to thepressure regulator 29 such as to be actuated by the driving air pressure P as generated on exhalation by the user through themouthpiece 5. - The
liquid dispensing unit 35 comprises abody member 37, in this embodiment a tubular member, here of cylindrical section, which defines anelongate cavity 39 which contains a metered dose of a liquid L, a dispensingmember 41 which is movably disposed in thecavity 39, such as to be moved along thecavity 39 under the action of the driving air pressure P and thereby dispense the liquid L from thecavity 39, and anoutlet nozzle 43 which is configured to provide for dispensing of the liquid L at a predetermined rate. - In this embodiment the
cavity 39 has a volume of about 1 ml. In another embodiment thecavity 39 could have a volume of or less than about 200 μl. - In this embodiment the dispensing
member 41 is initially disposed at one end of thecavity 39 adjacent theflow regulator 29 and is moved to the other end of thecavity 39 under the action of the driving air pressure, with the liquid L as contained in thecavity 39 being progressively dispensed as the dispensingmember 41 is moved along thecavity 39. - In this embodiment the dispensing
member 41 and thecavity 39 of theliquid dispensing unit 35 are configured to provide for movement with a driving air pressure P at or less than about 5 kPa and preferably at or less than about 3 kPa. - In this embodiment the dispensing
member 41 is a ball which sealingly engages the peripheral wall of thecavity 39. - The
outlet nozzle 43 includes anoutlet orifice 45 which is shaped and dimensioned, in this embodiment having a circular section, to provide the dispensed liquid with a predetermined profile. In this embodiment theoutlet orifice 45 is configured to dispense the liquid L such that the flow of liquid L remains substantially rectilinear for a distance of at least about 15 mm, preferably at least about 20 mm, more preferably at least about 25 mm and yet more preferably at least about 30 mm from the exit of theoutlet orifice 45 and thereafter provide a dispersed aerosol spray, as illustrated inFIG. 3( a). In an alternative embodiment theoutlet orifice 45 can be configured to provide a liquid jet, either with some dispersion in the form of a shower of droplets, as illustrated inFIG. 3( b), or with no dispersion, as illustrated inFIG. 3( c). - In preferred embodiments the
outlet orifice 45 has a diameter of at or less than about 3 mm, preferably at or less than about 2 mm, and more preferably at or less than about 1 mm. - In this embodiment the
outlet nozzle 43 includes a frangible membrane which normally encloses theoutlet orifice 45 thereof such as to contain the liquid L and is ruptured on the application of the driving air pressure P to the liquid L. - The delivery device further comprises a second,
outlet housing part 51 which defines anosepiece 53 at one, outlet end thereof and anoutlet chamber 57, in this embodiment an annular chamber surrounding thebody member 37 of theliquid dispensing unit 35, which is in fluid communication with the entrainingair flow channels 23 in thebaffle member 11 and opens to an outlet end thereof, such that exhalation by a user into themouthpiece 5 delivers an entraining air flow F into theoutlet chamber 57 and to the open, outlet end thereof. - The delivery device further comprises a
flow regulator 61 which encloses theannular outlet chamber 57 at the outlet end of thebody member 37 of theliquid dispensing unit 35. - In this embodiment the
flow regulator 61 includes a plurality offlow apertures 63, in this embodiment sixteen apertures, which are located on an annulus surrounding thebody member 37 of theliquid dispensing unit 35, such as to provide for the delivery of a substantially annular entraining air flow F which entrains the liquid L as dispensed from the liquid-containingcavity 39 of theliquid dispensing unit 35. - In this embodiment the
flow regulator 61 is configured to provide for a flow rate of at least about 20 l/min, more preferably at least about 30 l/min, still more preferably at least about 40 l/min and yet more preferably at least about 50 l/min. - In this embodiment the
flow apertures 63 have a circular section, here of a diameter of at or less than about 1 mm. - Operation of the above-described delivery device will now be described hereinbelow with reference to
FIG. 4 of the accompanying drawings. - A user first inserts the
nosepiece 53 into one of his/her nostrils and then grips themouthpiece 5 in his/her lips. It should be understood that, for the sake of ease of illustration, the delivery device has been illustrated in an elongate configuration where thenosepiece 53 and themouthpiece 5 are located on a common axis. In practice, thenosepiece 53 and themouthpiece 5 would be inclined relative to one another, such as to facilitate fitting of thenosepiece 53 and themouthpiece 5 in respective ones of a nostril and the lips. - The user then exhales through the
mouthpiece 5, which is in fluid communication with theinlet chamber 7. - This exhalation acts to generate a driving air pressure P at the driving
air pressure channel 21 in thebaffle member 11 and an entraining air flow F through the entrainingair flow channels 23 in thebaffle member 11, which entraining air flow F continues through theoutlet chamber 57 and theflow apertures 63 in the entrainingair flow regulator 61, which define a substantially annular entraining air flow F which surrounds the outlet end of theliquid dispensing unit 35. - The driving air pressure P as created at the driving
air pressure channel 21 simultaneously acts on the dispensingmember 41, which is located in thecavity 39 of theliquid dispensing unit 35, such as to move the same along thecavity 39 and dispense the liquid L as contained therein from the outlet end thereof into the entraining air flow F, which surrounds the same, thereby providing for delivery of the liquid L, in this embodiment into the nasal cavity of the user. - In this embodiment the delivery device, in providing for the delivery of the liquid L in an entraining air flow F, advantageously provides for delivery into and through the nasal airway in the manner as described in the applicant's earlier WO-A-2000/051672, the content of which is herein incorporated by reference.
- Finally, it will be understood that the present invention has been described in its preferred embodiment and can be modified in many different ways without departing from the scope of the invention as defined by the appended claims.
- In one modification, as illustrated in
FIGS. 5 and 6 , the delivery device can further comprise aflow restrictor 71 at the outlet end of theoutlet housing part 51 which defines thenosepiece 53. In this embodiment theflow restrictor 71 tapers inwardly, here with a frusto-conical section 73, towards the outlet end of theoutlet housing part 51. In this embodiment theflow restrictor 71 defines an outlet which has a circular section. In preferred embodiments the outlet of theflow restrictor 71 has a diameter of at or less than about 8 mm, preferably at or less than about 6 mm and more preferably at or less than about 4 mm, and the angle of thetapering section 73 of theflow restrictor 71 has an angle of at or less than about 60 degrees, preferably at or less than about 55 degrees and more preferably at or less than about 52 degrees relative to a plane perpendicular to the longitudinal axis of theoutlet housing part 51. With this configuration, a faster delivery of the liquid L can be achieved as compared to the above-described embodiment.
Claims (25)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/133,356 US20170043108A1 (en) | 2006-11-28 | 2016-04-20 | Delivery devices |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0623731.7 | 2006-11-28 | ||
GBGB0623731.7A GB0623731D0 (en) | 2006-11-28 | 2006-11-28 | Delivery device |
PCT/IB2007/004353 WO2008081326A2 (en) | 2006-11-28 | 2007-11-28 | Delivery devices |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2007/004353 A-371-Of-International WO2008081326A2 (en) | 2006-11-28 | 2007-11-28 | Delivery devices |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/171,554 Continuation US20150007811A1 (en) | 2006-11-28 | 2014-02-03 | Delivery devices |
Publications (1)
Publication Number | Publication Date |
---|---|
US20110023869A1 true US20110023869A1 (en) | 2011-02-03 |
Family
ID=37671442
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/516,401 Abandoned US20110023869A1 (en) | 2006-11-28 | 2007-11-28 | Delivery devices |
US14/171,554 Abandoned US20150007811A1 (en) | 2006-11-28 | 2014-02-03 | Delivery devices |
US15/133,356 Abandoned US20170043108A1 (en) | 2006-11-28 | 2016-04-20 | Delivery devices |
US15/936,251 Active 2028-07-07 US10639438B2 (en) | 2006-11-28 | 2018-03-26 | Delivery devices |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/171,554 Abandoned US20150007811A1 (en) | 2006-11-28 | 2014-02-03 | Delivery devices |
US15/133,356 Abandoned US20170043108A1 (en) | 2006-11-28 | 2016-04-20 | Delivery devices |
US15/936,251 Active 2028-07-07 US10639438B2 (en) | 2006-11-28 | 2018-03-26 | Delivery devices |
Country Status (3)
Country | Link |
---|---|
US (4) | US20110023869A1 (en) |
GB (2) | GB0623731D0 (en) |
WO (1) | WO2008081326A2 (en) |
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070039614A1 (en) * | 2003-05-20 | 2007-02-22 | Djupesland Per G | Delivery device and method |
US20070125371A1 (en) * | 2003-08-28 | 2007-06-07 | Optinose As | Delivery devices |
US20080161771A1 (en) * | 2001-02-26 | 2008-07-03 | Optinose As | Nasal delevery devices |
US20080289629A1 (en) * | 2004-09-15 | 2008-11-27 | Optinose As | Nasal Delivery Devices |
US20090101146A1 (en) * | 2002-07-02 | 2009-04-23 | Per Gisle Djupesland | Nasal devices |
US20090293873A1 (en) * | 2005-02-23 | 2009-12-03 | Optinose As | Powder delivery devices |
US20100091965A1 (en) * | 2007-12-13 | 2010-04-15 | Huawei Technologies Co., Ltd. | Service subscription method, system and server |
US20110053827A1 (en) * | 2006-06-08 | 2011-03-03 | Optinose As | Intranasal administration |
US9205208B2 (en) | 2001-06-12 | 2015-12-08 | Optinose As | Nasal devices |
US20160015915A1 (en) * | 2013-03-06 | 2016-01-21 | Hsd Holding Smart Device S.R.L. | Element for Inhaling Medicinal Substances |
USD759805S1 (en) | 2013-05-23 | 2016-06-21 | Optinose As | Nosepiece unit |
US9452272B2 (en) | 2003-08-14 | 2016-09-27 | Optinose As | Delivery devices |
US9649456B2 (en) | 2007-04-05 | 2017-05-16 | Optinose As | Nasal administration |
US20170304568A1 (en) * | 2014-09-02 | 2017-10-26 | Université François-Rabelais De Tours | Device for nasal spraying of fluid product |
US9949923B2 (en) | 2011-03-15 | 2018-04-24 | Optinose As | Nasal delivery |
US20180126101A1 (en) * | 2011-05-09 | 2018-05-10 | Impel Neuropharma Inc. | Nozzles for nasal drug delivery |
US10076615B2 (en) | 2007-04-05 | 2018-09-18 | Optinose As | Nasal delivery |
US10076602B2 (en) | 2013-11-05 | 2018-09-18 | Benedict GERBER | Nasal douche with valve that can be actuated by respiratory air |
US10076614B2 (en) | 2012-02-24 | 2018-09-18 | Optinose As | Nasal delivery devices |
US10124132B2 (en) | 2006-03-06 | 2018-11-13 | Optinose As | Nasal delivery |
US10179216B2 (en) | 2012-02-24 | 2019-01-15 | Optinose As | Nasal delivery devices |
US10252010B2 (en) | 2007-10-03 | 2019-04-09 | Optinose As | Nasal delivery devices |
US10300229B2 (en) | 2012-02-24 | 2019-05-28 | Optinose As | Nasal delivery devices |
US10478574B2 (en) | 2006-01-19 | 2019-11-19 | Optinose As | Nasal administration |
US10525218B2 (en) | 2006-11-28 | 2020-01-07 | Optinose As | Nasal delivery devices |
US10639437B2 (en) | 2006-11-28 | 2020-05-05 | Optinose As | Delivery devices |
US10639438B2 (en) | 2006-11-28 | 2020-05-05 | Optinose As | Delivery devices |
US10765829B2 (en) | 2006-07-25 | 2020-09-08 | Optinose As | Delivery of gases to the nasal airway |
US10864334B2 (en) | 2006-03-23 | 2020-12-15 | Optinose As | Nasal delivery |
US10940277B2 (en) | 2014-11-19 | 2021-03-09 | Optinose As | Intranasal administration |
US11291626B2 (en) | 2010-09-14 | 2022-04-05 | Optinose As | Nasal delivery of oxytocin |
US11554229B2 (en) | 2013-03-26 | 2023-01-17 | OptiNose Inc. | Nasal administration |
US12083270B2 (en) | 2006-02-14 | 2024-09-10 | OptiNose Inc. | Delivery device and method |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103272315B (en) * | 2013-04-28 | 2019-02-22 | 河南科技大学第一附属医院 | A kind of inhalation device of the upper respiratory tract |
US11925749B2 (en) * | 2021-03-18 | 2024-03-12 | Funai Electric Co., Ltd. | Venting of pharmaceutical drug delivery device for air flow and humidity control |
Citations (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4820306A (en) * | 1981-06-22 | 1989-04-11 | Sterling Drug Inc. | Method for augmentation of the alveolar ridge |
WO2003084591A1 (en) * | 2002-04-04 | 2003-10-16 | Optinose As | Nasal devices |
US6715485B1 (en) * | 1999-03-03 | 2004-04-06 | Optinose As | Nasal delivery device |
US20040112379A1 (en) * | 2001-02-26 | 2004-06-17 | Djupesland Per Gisle | Nasal devices |
US20050028812A1 (en) * | 2000-11-15 | 2005-02-10 | Per Gisle Djupesland | Nasal delivery device |
US20050072430A1 (en) * | 2001-06-12 | 2005-04-07 | Per Gisle Djupesland | Nasal devices |
US20050235992A1 (en) * | 2002-03-28 | 2005-10-27 | Djupesland Per G | Nasal devices |
US20060096589A1 (en) * | 2002-04-25 | 2006-05-11 | Djupesland Per G | Nasal devices |
US20060169278A1 (en) * | 2002-07-09 | 2006-08-03 | Djupesland Per G | Delivery devices |
US20070039614A1 (en) * | 2003-05-20 | 2007-02-22 | Djupesland Per G | Delivery device and method |
US20070125371A1 (en) * | 2003-08-28 | 2007-06-07 | Optinose As | Delivery devices |
US20070186927A1 (en) * | 2003-08-14 | 2007-08-16 | Djupesland Per G | Delivery devices |
US7377901B2 (en) * | 2000-06-21 | 2008-05-27 | Optinose As | Apparatus for collection of airway gases |
US20080289629A1 (en) * | 2004-09-15 | 2008-11-27 | Optinose As | Nasal Delivery Devices |
US7481218B2 (en) * | 2002-07-02 | 2009-01-27 | Optinose As | Nasal devices |
US20090293873A1 (en) * | 2005-02-23 | 2009-12-03 | Optinose As | Powder delivery devices |
US20090304802A1 (en) * | 2006-03-03 | 2009-12-10 | Optinose As | Nasal delivery |
US20090314293A1 (en) * | 2006-03-06 | 2009-12-24 | Optinose As | Nasal delivery |
US20090320832A1 (en) * | 2006-03-23 | 2009-12-31 | Optinose As | Nasal delivery |
US20100035805A1 (en) * | 2006-04-25 | 2010-02-11 | Optinose As | Non-aqueous liquid formulation for nasal or buccal administration |
US20100051022A1 (en) * | 2006-02-14 | 2010-03-04 | Optinose As | Delivery device and method |
US20100057047A1 (en) * | 2006-02-14 | 2010-03-04 | Optinose As | Delivery device and method |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US605436A (en) | 1898-06-07 | Inhaler | ||
US642748A (en) | 1899-02-23 | 1900-02-06 | Arthur Manners | Inhaler. |
US658436A (en) | 1900-05-28 | 1900-09-25 | Hans Hennerich Groth | Insufflator. |
US746749A (en) | 1903-03-18 | 1903-12-15 | George E Seidel | Nasal medicator. |
US794641A (en) | 1905-03-06 | 1905-07-11 | Alfred H Ramey | Inhaler. |
US902832A (en) | 1907-09-20 | 1908-11-03 | Edward F Philbrook | Inhaler. |
PT805696E (en) | 1995-01-23 | 2000-08-31 | Direct Haler A S | INHALER |
US5797392C1 (en) | 1996-01-22 | 2001-01-09 | Direct Haler As | Inhaler |
TR199902899T2 (en) | 1997-05-27 | 2000-05-22 | Direct-Haler A/S | A device for inhaling drugs used in powder form. |
GB0300008D0 (en) | 2003-01-02 | 2003-02-05 | Optinose As | Delivery devices |
USD530815S1 (en) | 2004-03-19 | 2006-10-24 | Optinose As | Nasal delivery device |
EP1984049A1 (en) | 2006-01-19 | 2008-10-29 | Optinose AS | Nasal administration |
GB2438834A (en) | 2006-06-08 | 2007-12-12 | Optinose As | Intranasal protein administration |
GB2440316A (en) | 2006-07-25 | 2008-01-30 | Optinose As | Nasal inhaler with scrubber |
GB0623731D0 (en) | 2006-11-28 | 2007-01-10 | Optinose As | Delivery device |
GB0623732D0 (en) | 2006-11-28 | 2007-01-10 | Optinose As | Powder delivery devices |
GB0623728D0 (en) | 2006-11-28 | 2007-01-10 | Optinose As | Delivery devices |
US20100199984A1 (en) | 2007-04-02 | 2010-08-12 | Abbott Laboratories | Breath actuated nasal pump |
GB2448183A (en) | 2007-04-05 | 2008-10-08 | Optinose As | Nasal powder delivery device |
GB2448193A (en) | 2007-04-05 | 2008-10-08 | Optinose As | Nasal delivery device |
GB0719299D0 (en) | 2007-10-03 | 2007-11-14 | Optinose As | Nasal delivery devices |
WO2009102976A2 (en) | 2008-02-15 | 2009-08-20 | Timothy Sean Immel | Aerosol therapy device with high frequency delivery |
WO2010029441A2 (en) | 2008-09-15 | 2010-03-18 | Optinose As | Nasal delivery |
GB201015371D0 (en) | 2010-09-14 | 2010-10-27 | Optinose As | Nasal delivery |
US9949923B2 (en) | 2011-03-15 | 2018-04-24 | Optinose As | Nasal delivery |
EP3281664B8 (en) | 2012-02-24 | 2020-12-30 | Optinose AS | Nasal delivery devices |
KR20150003725A (en) | 2012-02-24 | 2015-01-09 | 옵티노즈 에이에스 | Nasal delivery devices |
PL2817053T3 (en) | 2012-02-24 | 2019-01-31 | Optinose As | Nasal delivery devices |
WO2014155192A2 (en) | 2013-03-26 | 2014-10-02 | Optinose As | Nasal administration |
US11554229B2 (en) | 2013-03-26 | 2023-01-17 | OptiNose Inc. | Nasal administration |
USD761951S1 (en) | 2013-05-23 | 2016-07-19 | Optinose As | Nosepiece unit |
USD723156S1 (en) | 2013-05-23 | 2015-02-24 | Optinose As | Nasal delivery device |
USD725769S1 (en) | 2013-05-23 | 2015-03-31 | Optinose As | Nasal delivery device |
KR20170086599A (en) | 2014-11-19 | 2017-07-26 | 옵티노즈 에이에스 | Intranasal Administration |
-
2006
- 2006-11-28 GB GBGB0623731.7A patent/GB0623731D0/en not_active Ceased
-
2007
- 2007-11-28 US US12/516,401 patent/US20110023869A1/en not_active Abandoned
- 2007-11-28 GB GB0723295A patent/GB2444394B/en not_active Expired - Fee Related
- 2007-11-28 WO PCT/IB2007/004353 patent/WO2008081326A2/en active Application Filing
-
2014
- 2014-02-03 US US14/171,554 patent/US20150007811A1/en not_active Abandoned
-
2016
- 2016-04-20 US US15/133,356 patent/US20170043108A1/en not_active Abandoned
-
2018
- 2018-03-26 US US15/936,251 patent/US10639438B2/en active Active
Patent Citations (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4820306A (en) * | 1981-06-22 | 1989-04-11 | Sterling Drug Inc. | Method for augmentation of the alveolar ridge |
US20060219240A1 (en) * | 1999-03-03 | 2006-10-05 | Djupesland Per G | Nasal delivery device |
US20060225732A1 (en) * | 1999-03-03 | 2006-10-12 | Djupesland Per G | Nasal delivery device |
US20040182388A1 (en) * | 1999-03-03 | 2004-09-23 | Djupesland Per Gisle | Nasal delivery method |
US20080223363A1 (en) * | 1999-03-03 | 2008-09-18 | Optinose As | Nasal Delivery Devices |
US6715485B1 (en) * | 1999-03-03 | 2004-04-06 | Optinose As | Nasal delivery device |
US20060219241A1 (en) * | 1999-03-03 | 2006-10-05 | Djupesland Per G | Nasal delivery device |
US20060231094A1 (en) * | 1999-03-03 | 2006-10-19 | Djupesland Per G | Nasal delivery device |
US20080221471A1 (en) * | 2000-06-21 | 2008-09-11 | Per Djupesland | Apparatus for collection of airway gases |
US7377901B2 (en) * | 2000-06-21 | 2008-05-27 | Optinose As | Apparatus for collection of airway gases |
US20050028812A1 (en) * | 2000-11-15 | 2005-02-10 | Per Gisle Djupesland | Nasal delivery device |
US7543581B2 (en) * | 2001-02-26 | 2009-06-09 | Optinose As | Nasal devices |
US7347201B2 (en) * | 2001-02-26 | 2008-03-25 | Optinose As | Nasal delivery devices |
US20040112379A1 (en) * | 2001-02-26 | 2004-06-17 | Djupesland Per Gisle | Nasal devices |
US20080161771A1 (en) * | 2001-02-26 | 2008-07-03 | Optinose As | Nasal delevery devices |
US7740014B2 (en) * | 2001-02-26 | 2010-06-22 | Optinose As | Nasal devices |
US20050072430A1 (en) * | 2001-06-12 | 2005-04-07 | Per Gisle Djupesland | Nasal devices |
US20080163874A1 (en) * | 2001-09-06 | 2008-07-10 | Optinose As | Nasal delivery device |
US20050235992A1 (en) * | 2002-03-28 | 2005-10-27 | Djupesland Per G | Nasal devices |
WO2003084591A1 (en) * | 2002-04-04 | 2003-10-16 | Optinose As | Nasal devices |
US20060096589A1 (en) * | 2002-04-25 | 2006-05-11 | Djupesland Per G | Nasal devices |
US7481218B2 (en) * | 2002-07-02 | 2009-01-27 | Optinose As | Nasal devices |
US20090101146A1 (en) * | 2002-07-02 | 2009-04-23 | Per Gisle Djupesland | Nasal devices |
US20060169278A1 (en) * | 2002-07-09 | 2006-08-03 | Djupesland Per G | Delivery devices |
US20070039614A1 (en) * | 2003-05-20 | 2007-02-22 | Djupesland Per G | Delivery device and method |
US20070186927A1 (en) * | 2003-08-14 | 2007-08-16 | Djupesland Per G | Delivery devices |
US20070125371A1 (en) * | 2003-08-28 | 2007-06-07 | Optinose As | Delivery devices |
US20080289629A1 (en) * | 2004-09-15 | 2008-11-27 | Optinose As | Nasal Delivery Devices |
US20090293873A1 (en) * | 2005-02-23 | 2009-12-03 | Optinose As | Powder delivery devices |
US20100051022A1 (en) * | 2006-02-14 | 2010-03-04 | Optinose As | Delivery device and method |
US20100057047A1 (en) * | 2006-02-14 | 2010-03-04 | Optinose As | Delivery device and method |
US20090304802A1 (en) * | 2006-03-03 | 2009-12-10 | Optinose As | Nasal delivery |
US20090314293A1 (en) * | 2006-03-06 | 2009-12-24 | Optinose As | Nasal delivery |
US20090320832A1 (en) * | 2006-03-23 | 2009-12-31 | Optinose As | Nasal delivery |
US20100035805A1 (en) * | 2006-04-25 | 2010-02-11 | Optinose As | Non-aqueous liquid formulation for nasal or buccal administration |
Cited By (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8511303B2 (en) | 1999-03-03 | 2013-08-20 | Optinose As | Nasal delivery devices |
US20080223363A1 (en) * | 1999-03-03 | 2008-09-18 | Optinose As | Nasal Delivery Devices |
US9468727B2 (en) | 2000-11-15 | 2016-10-18 | Optinose As | Nasal delivery |
US20080161771A1 (en) * | 2001-02-26 | 2008-07-03 | Optinose As | Nasal delevery devices |
US8522778B2 (en) | 2001-02-26 | 2013-09-03 | Optinose As | Nasal devices |
US20110088691A1 (en) * | 2001-02-26 | 2011-04-21 | Per Gisle Djupesland | Nasal Devices |
US9205208B2 (en) | 2001-06-12 | 2015-12-08 | Optinose As | Nasal devices |
US9522243B2 (en) | 2002-07-02 | 2016-12-20 | Optinose As | Nasal devices |
US20090101146A1 (en) * | 2002-07-02 | 2009-04-23 | Per Gisle Djupesland | Nasal devices |
US9132249B2 (en) | 2002-07-02 | 2015-09-15 | Optinose As | Nasal devices |
US8047202B2 (en) | 2002-07-02 | 2011-11-01 | Optinose As | Nasal devices |
US20070039614A1 (en) * | 2003-05-20 | 2007-02-22 | Djupesland Per G | Delivery device and method |
US10286164B2 (en) | 2003-05-20 | 2019-05-14 | Optinose As | Delivery device and method |
US9566402B2 (en) | 2003-05-20 | 2017-02-14 | Optinose As | Delivery Device and Method |
US9452272B2 (en) | 2003-08-14 | 2016-09-27 | Optinose As | Delivery devices |
US20070125371A1 (en) * | 2003-08-28 | 2007-06-07 | Optinose As | Delivery devices |
US10737045B2 (en) | 2003-08-28 | 2020-08-11 | Optinose As | Delivery devices |
US8590530B2 (en) | 2004-09-15 | 2013-11-26 | Optinose As | Nasal delivery devices |
US9108015B2 (en) | 2004-09-15 | 2015-08-18 | Optinose As | Nasal delivery devices |
US20080289629A1 (en) * | 2004-09-15 | 2008-11-27 | Optinose As | Nasal Delivery Devices |
US10398859B2 (en) | 2004-09-15 | 2019-09-03 | Optinose As | Nasal delivery devices |
US20150101605A1 (en) * | 2005-02-23 | 2015-04-16 | Optinose As | Powder delivery devices |
US20090293873A1 (en) * | 2005-02-23 | 2009-12-03 | Optinose As | Powder delivery devices |
US9144652B2 (en) * | 2005-02-23 | 2015-09-29 | Optinose As | Powder delivery devices |
US11571531B2 (en) | 2005-02-23 | 2023-02-07 | OptiNose Inc. | Powder delivery devices |
US8899229B2 (en) | 2005-02-23 | 2014-12-02 | Optinose As | Powder delivery devices |
US10478574B2 (en) | 2006-01-19 | 2019-11-19 | Optinose As | Nasal administration |
US12083270B2 (en) | 2006-02-14 | 2024-09-10 | OptiNose Inc. | Delivery device and method |
US10124132B2 (en) | 2006-03-06 | 2018-11-13 | Optinose As | Nasal delivery |
US10864334B2 (en) | 2006-03-23 | 2020-12-15 | Optinose As | Nasal delivery |
US20110053827A1 (en) * | 2006-06-08 | 2011-03-03 | Optinose As | Intranasal administration |
US10112021B2 (en) | 2006-06-08 | 2018-10-30 | Optinose As | Intranasal administration |
US11690969B2 (en) | 2006-07-25 | 2023-07-04 | OptiNose Inc. | Delivery of gases to the nasal airway |
US10765829B2 (en) | 2006-07-25 | 2020-09-08 | Optinose As | Delivery of gases to the nasal airway |
US10525218B2 (en) | 2006-11-28 | 2020-01-07 | Optinose As | Nasal delivery devices |
US10639437B2 (en) | 2006-11-28 | 2020-05-05 | Optinose As | Delivery devices |
US10639438B2 (en) | 2006-11-28 | 2020-05-05 | Optinose As | Delivery devices |
US10076615B2 (en) | 2007-04-05 | 2018-09-18 | Optinose As | Nasal delivery |
US9649456B2 (en) | 2007-04-05 | 2017-05-16 | Optinose As | Nasal administration |
US10722667B2 (en) | 2007-04-05 | 2020-07-28 | Optinose As | Nasal administration |
US11083858B2 (en) | 2007-10-03 | 2021-08-10 | Optinose As | Nasal delivery devices |
US11602603B2 (en) | 2007-10-03 | 2023-03-14 | Optinose, Inc. | Nasal delivery devices |
US10252010B2 (en) | 2007-10-03 | 2019-04-09 | Optinose As | Nasal delivery devices |
US20100091965A1 (en) * | 2007-12-13 | 2010-04-15 | Huawei Technologies Co., Ltd. | Service subscription method, system and server |
US11291626B2 (en) | 2010-09-14 | 2022-04-05 | Optinose As | Nasal delivery of oxytocin |
US9949923B2 (en) | 2011-03-15 | 2018-04-24 | Optinose As | Nasal delivery |
RU2741249C2 (en) * | 2011-05-09 | 2021-01-22 | Импел Ньюрофарма Инк. | Tips for nasal drug delivery |
US10940278B2 (en) | 2011-05-09 | 2021-03-09 | Impel Neuropharma, Inc. | Nozzles for nasal drug delivery |
US20180126101A1 (en) * | 2011-05-09 | 2018-05-10 | Impel Neuropharma Inc. | Nozzles for nasal drug delivery |
US11007332B2 (en) * | 2011-05-09 | 2021-05-18 | Impel Neuropharma, Inc. | Nozzles for nasal drug delivery |
US11890412B2 (en) | 2011-05-09 | 2024-02-06 | Impel Pharmaceuticals Inc. | Nozzles for nasal drug delivery |
US11033696B2 (en) | 2012-02-24 | 2021-06-15 | Optinose As | Nasal delivery devices |
US10300229B2 (en) | 2012-02-24 | 2019-05-28 | Optinose As | Nasal delivery devices |
US10076614B2 (en) | 2012-02-24 | 2018-09-18 | Optinose As | Nasal delivery devices |
US10179216B2 (en) | 2012-02-24 | 2019-01-15 | Optinose As | Nasal delivery devices |
US20160015915A1 (en) * | 2013-03-06 | 2016-01-21 | Hsd Holding Smart Device S.R.L. | Element for Inhaling Medicinal Substances |
US10220168B2 (en) * | 2013-03-06 | 2019-03-05 | Hsd Holding Smart Device S.R.L. | Element for inhaling medicinal substances |
US11554229B2 (en) | 2013-03-26 | 2023-01-17 | OptiNose Inc. | Nasal administration |
USD761951S1 (en) | 2013-05-23 | 2016-07-19 | Optinose As | Nosepiece unit |
USD759805S1 (en) | 2013-05-23 | 2016-06-21 | Optinose As | Nosepiece unit |
USD809128S1 (en) | 2013-05-23 | 2018-01-30 | Optinose As | Nosepiece unit |
US10076602B2 (en) | 2013-11-05 | 2018-09-18 | Benedict GERBER | Nasal douche with valve that can be actuated by respiratory air |
US20170304568A1 (en) * | 2014-09-02 | 2017-10-26 | Université François-Rabelais De Tours | Device for nasal spraying of fluid product |
US10814079B2 (en) * | 2014-09-02 | 2020-10-27 | Universite De Tours | Device for nasal spraying of fluid product |
US11052204B2 (en) | 2014-11-19 | 2021-07-06 | Optinose As | Intranasal administration |
US11707586B2 (en) | 2014-11-19 | 2023-07-25 | OptiNose Inc. | Intranasal administration |
US11730904B2 (en) | 2014-11-19 | 2023-08-22 | Optinose, Inc. | Intranasal administration |
US10940277B2 (en) | 2014-11-19 | 2021-03-09 | Optinose As | Intranasal administration |
Also Published As
Publication number | Publication date |
---|---|
WO2008081326A2 (en) | 2008-07-10 |
US10639438B2 (en) | 2020-05-05 |
US20170043108A1 (en) | 2017-02-16 |
GB0623731D0 (en) | 2007-01-10 |
GB2444394B (en) | 2011-05-18 |
US20150007811A1 (en) | 2015-01-08 |
GB0723295D0 (en) | 2008-01-09 |
WO2008081326A3 (en) | 2008-10-23 |
US20190099565A1 (en) | 2019-04-04 |
GB2444394A (en) | 2008-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10639438B2 (en) | Delivery devices | |
US9038630B2 (en) | Delivery devices | |
US20210196904A1 (en) | Mixing channel for an inhalation device and inhalation device | |
AU712312B2 (en) | Breathing circuit apparatus for a nebulizer | |
CN106573117B (en) | Liquid medicament cartridge and related dispenser | |
US5655520A (en) | Flexible valve for administering constant flow rates of medicine from a nebulizer | |
CA2377566C (en) | Low spray force, low retention atomization system | |
US5297543A (en) | Medication inhaler mixer | |
EP0520571A1 (en) | Atomising nozzle | |
US20120227735A1 (en) | Nebulizer for a aerosoltherapy | |
JP2007535352A (en) | Nebulizer for administering medical fluids | |
JP2005530535A (en) | System including nozzle and fixing means thereof | |
CN101980738A (en) | Circumferential aerosol device | |
US20220096759A1 (en) | Nebulizer and Reservoir | |
DK142132B (en) | Aerosol nebulizer with manually operated atomisers. | |
JPH09502921A (en) | Discharge device for flowable media | |
US20050023295A1 (en) | Dosing device with an application top | |
GB2476731A (en) | Delivery device | |
GB2461433A (en) | Delivery devices |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: OPTINOSE AS, NORWAY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DJUPESLAND, PER GISLE;REEL/FRAME:023082/0779 Effective date: 20090806 |
|
AS | Assignment |
Owner name: OPTINOSE AS, NORWAY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DJUPESLAND, PER GISLE;ANDREASSEN, ERIK;GAARDER, RUNE HARALD;AND OTHERS;SIGNING DATES FROM 20100525 TO 20100709;REEL/FRAME:031242/0896 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: OPTINOSE AS, NORWAY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DJUPESLAND, PER GISLE;ANDREASSEN, ERIK;GAARDER, RUNE HARALD;AND OTHERS;SIGNING DATES FROM 20100525 TO 20100709;REEL/FRAME:042705/0719 Owner name: OPTINOSE AS, NORWAY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DJUPESLAND, PER GISLE;ANDREASSEN, ERIK;GAARDER, RUNE HARALD;AND OTHERS;SIGNING DATES FROM 20100525 TO 20110831;REEL/FRAME:042705/0885 |